MtETC in M2 macrophage polarization
Role of mtETC in M2 macrophage polarization. IL-4 and IL-13 stimulate reprogramming of macrophages toward the pro-inflammatory phenotype. During this metabolic reprogramming, the TCA cycle remains intact and supplies an ample number of electrons at mtETC, particularly at C I and C II. The electrons flow from C I to C IV in a sequential manner (known as FET; see abbreviations below), which results in ATP production by OXPHOS, and low mtROS production as well. M2 macrophages do not rely on glycolysis as long as OXPHOS is intact; these cells express PFKFB1 which efficiently catalyses fructose 2,6-BisP to fructose-6-phosphate, eventually reducing the glycolytic rate. In addition, the activity of oxidative PPP is also reduced due to enhanced expression of CARKL, and the generated products are utilized for nucleotide production and UDP-GlcNAc synthesis. UDP-GlcNAc is crucial for N-glycosylation for several cell surface proteins in M2 macrophages. Glucose is utilized for UDP-GlcNAc as well. Besides glutaminolysis, the synthesis of glutamine is also enhanced via the upregulation of glutamine synthetase, and glutamine is crucial for the synthesis of UDP-GlcNAc. M2 macrophages rely on fatty acid oxidation, and CD36 expression level is enhanced in M2 macrophages which facilitates increased uptake of fatty acids. CPT1 translocates fatty acids from the cytosol in the mitochondria for its oxidation which yields Acetyl CoA (shown by broken black arrow) that enters into the TCA cycle. IL-4 and IL-13 stimulation triggers PGC-1β and STAT6 phosphorylation that induces expression of nuclear receptor PPARγ. PPARγ stimulates the expression of CD36, and PGC-1β co-activates STAT6 transcription. Glutaminolysis is enhanced in M2 macrophages which elevates the levels of α-ketoglutarate via GLS. M2 macrophages express Arginase 1 that catalyses conversion of arginine to L-ornithine and urea. L-ornithine is further metabolized by ODC which yields L-proline and polyamines, the latter molecules are crucial for tissue repair. The black solid arrows represent the movement of substrates, the broken blue arrows represent the activation of enzymatic and signaling pathways in M2 macrophages, the broken red line represent the inhibition of the enzymes/pathways in M2 macrophages. The abbreviations used are: IL-4R, IL-4 receptor; CD36, cluster of differentiation 36; CPT1, carnitine palmitoyltransferase I, PFKFB1, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1, PPARγ, peroxisome proliferator-activated receptor γ; PGC-1β, PPARγ coactivator-β; Arg1, Arginase 1; STAT6, signal transducer and activator of transcription 6; GS, glutamine synthetase; GLS, glutaminase; FET, forward electron transfer. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Publication
Mitochondrial electron transport chain in macrophage reprogramming: Potential role in antibacterial immune response (2024) Manmohan Kumar, et al. Curr Res Immunol. 2024;5(NA). Figure: F10.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Hexokinase | HEXOKINASE | ncbigene_synonym | HK1 | 3098 |
| Homo sapiens | Primates | Hexokinase | HEXOKINASE | famplex_relations | GCK | 2645 |
| Homo sapiens | Primates | Hexokinase | HEXOKINASE | famplex_relations | HK2 | 3099 |
| Homo sapiens | Primates | Hexokinase | HEXOKINASE | famplex_relations | HK3 | 3101 |
| Homo sapiens | Primates | IL-4R | IL4R | ncbigene_symbol | IL4R | 3566 |
| Homo sapiens | Primates | IL-4, | IL-4 | ncbigene_synonym | IL4 | 3565 |
| Homo sapiens | Primates | IL-13R | IL-13R | ncbigene_synonym | IL13RA2 | 3598 |
| Homo sapiens | Primates | IL-13 | IL-13 | ncbigene_synonym | IL13 | 3596 |
| Homo sapiens | Primates | CARKL | CARKL | ncbigene_synonym | SHPK | 23729 |
| Homo sapiens | Primates | STAT6 | STAT6 | ncbigene_symbol | STAT6 | 6778 |
| Homo sapiens | Primates | CD36 | CD36 | ncbigene_symbol | CD36 | 948 |
| Homo sapiens | Primates | PFKFB1 | PFKFB1 | ncbigene_symbol | PFKFB1 | 5207 |
| Homo sapiens | Primates | F2,6-BisP | F2 | ncbigene_symbol | F2 | 2147 |
| Homo sapiens | Primates | PGC-1B | PGC1B | ncbigene_synonym | PPARGC1B | 133522 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | CPT1 | CPT1 | ncbigene_synonym | CPT1A | 1374 |
| Homo sapiens | Primates | CPT1 | CPT1 | ncbigene_synonym | CPT2 | 1376 |
| Homo sapiens | Primates | CPT1 | CPT1 | ncbigene_synonym | CHPT1 | 56994 |
| Homo sapiens | Primates | PKM2 | PKM2 | ncbigene_synonym | PKM | 5315 |
| Homo sapiens | Primates | PKM2 | PKM2 | famplex_relations | PKLR | 5313 |
| Homo sapiens | Primates | PDH | PDH | ncbigene_synonym | PDP1 | 54704 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | DLAT | 1737 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | DLD | 1738 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | PDHA1 | 5160 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | PDHA2 | 5161 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | PDHB | 5162 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | PDHX | 8050 |
| Homo sapiens | Primates | ODC | ODC | ncbigene_synonym | ODC1 | 4953 |
| Homo sapiens | Primates | ODC | ODC | ncbigene_synonym | SLC25A21 | 89874 |
| Homo sapiens | Primates | GS | GS | famplex_relations | GNAS | 2778 |
| Homo sapiens | Primates | GS | GS | famplex_relations | GNAL | 2774 |
| Homo sapiens | Primates | GLS | GLS | ncbigene_symbol | GLS | 2744 |
| Homo sapiens | Primates | GLS | GLS | ncbigene_synonym | GLS2 | 27165 |
| Homo sapiens | Primates | ATP | ATP | ncbigene_synonym | ATP8A2 | 51761 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| Fatty acids | fatty acids | fatty acids | chebi:35366 | |
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| PPP | PPP | L-prolyl-L-prolyl-L-proline | chebi:73647 | |
| Fatty acids | fatty acids | fatty acids | chebi:35366 | |
| Urea | urea | urea | chebi:16199 | |
| Lactate | lactate | lactate | chebi:24996 | |
| Citrate | citrate | chebi:133748 | ||
| Oxaloacetate | oxaloacetate | 2-oxobutanedioate | chebi:16452 | |
| L-Ornithine | L-ornithine | L-ornithine | chebi:46911 | |
| GlcNAc | GlcNAc | N-acetyl-D-glucosamine | chebi:506227 | |
| Malate | Malate | (2S)-2-hydroxybutanedioic acid | chebi:30797 | |
| Fumarate | fumarate | fumarate | chebi:29806 | |
| Succinate | succinate | succinate | chebi:30031 | |
| Glutamine | GLUTAMINE | L-glutamine | chebi:18050 | |
| acid | acid | acid | chebi:37527 | |
| Glutamate | Glutamate | (2S)-2-aminopentanedioic acid | chebi:16015 | |
| Succinyl | succinyl | butanedioyl | chebi:37952 | |
| CoA | CoA | 3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] diphosphate} | chebi:57287 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| ATP | ATP | ATP | chebi:30616 | |
| ATP | ATP | ATP | chebi:30616 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|